1. Home
  2. TSLX vs OGN Comparison

TSLX vs OGN Comparison

Compare TSLX & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sixth Street Specialty Lending Inc.

TSLX

Sixth Street Specialty Lending Inc.

HOLD

Current Price

$18.54

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$6.22

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TSLX
OGN
Founded
2010
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.7B
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
TSLX
OGN
Price
$18.54
$6.22
Analyst Decision
Buy
Hold
Analyst Count
9
4
Target Price
$21.72
$11.75
AVG Volume (30 Days)
1.5M
3.2M
Earning Date
05-14-2026
05-14-2026
Dividend Yield
11.24%
1.25%
EPS Growth
N/A
N/A
EPS
1.81
0.72
Revenue
N/A
$6,216,000,000.00
Revenue This Year
N/A
$0.42
Revenue Next Year
$1.92
$1.67
P/E Ratio
$10.08
$8.85
Revenue Growth
N/A
N/A
52 Week Low
$16.99
$6.18
52 Week High
$25.17
$15.85

Technical Indicators

Market Signals
Indicator
TSLX
OGN
Relative Strength Index (RSI) 46.00 29.30
Support Level $16.99 $6.18
Resistance Level $22.46 $7.87
Average True Range (ATR) 0.57 0.20
MACD 0.12 -0.03
Stochastic Oscillator 83.52 5.49

Price Performance

Historical Comparison
TSLX
OGN

About TSLX Sixth Street Specialty Lending Inc.

Sixth Street Specialty Lending Inc is a specialty finance company focused on providing flexible, fully committed financing solutions to middle market companies located in the United States of America. It partners with companies across a variety of industries and excel at providing creative solutions to companies with complex business models that may have limited access to capital. The company seeks to generate current income in U.S.-domiciled middle-market companies through direct originations of senior secured loans and, to a lesser extent, originations of mezzanine and unsecured loans and investments in corporate bonds and equity securities.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: